Fabian Svahn, Ana Castillo-Orozco, Mahsa Jalali, Sara Mahshid, David Juncker, Nada Jabado, Janusz W. Rak, Livia Garzia
Article de revue (2026)
Document publié alors que les auteurs ou autrices n'étaient pas affiliés à Polytechnique Montréal
Résumé
Medulloblastoma is one of the most frequent aggressive brain tumors in children. The emerging molecular complexity in the absence of targeted therapies, side effects of standard treatment, and metastatic progression signify the currently unmet need to develop liquid biopsy (LB) biomarkers to facilitate diagnostic and therapeutic challenges. In this article, we discuss the biology, complexity, and diagnostic applications of extracellular vesicles (EV) in cancer, and we survey the emerging evidence as to their possible role as LB analytes in medulloblastoma. We also explore how progress in nanotechnology may accelerate various approaches to exploit the rich molecular repertoire of EVs and their populations to improve the outcomes in children with these life-threatening brain tumors.
Mots clés
Mahsa Jalali
Sara Mahshid
David Juncker
Nada Jabado
Janusz W. Rak
Livia Garzia
Statistiques
Dimensions
